Catalent Inc Asset Turnover Ratio (CTLT), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Catalent Inc   (NYSE: CTLT)
 

Catalent Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2025, Catalent Inc 's asset turnover ratio sequentially decreased to 0.44 in the first quarter (Sep 30 2024), this is lower than usual.

Within sector 86 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 2199, from total ranking in the fourth quarter 2024 at 2486.

Asset Turnover Ratio Definition



CTLT Asset Turnover Ratio (Sep 30 2024)
I. Quarter
(Jun 30 2024)
IV. Quarter
(Mar 31 2024)
III. Quarter
(Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
Y / Y Asset Change 5.21 % -3.14 % -9.5 % -8.78 % -10.4 %
Y / Y Revenue Change 4.18 % 23.32 % 3.57 % -10.88 % -3.91 %
Asset Turnover Ratio (TTM) 0.44 0.45 0.42 0.4 0.41
CTLT's Total Ranking # 2199 # 2486 # 2109 # 1899 # 1690
Seq. Asset Change 8.24 % -0.46 % -1.28 % -1.09 % -0.35 %
Seq. Revenue Change -21.37 % 21.14 % 4.88 % 4.28 % -6.92 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 319
Overall Market # 2199

Asset Turnover Ratio Statistics
High Average Low
0.64 0.51 0.39
(Jun 30 2017)   (Dec 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Koru Medical Systems Inc   1.16 $ 31.994  Millions$ 27.664  Millions
Idexx Laboratories Inc  1.15 $ 3,843.430  Millions$ 3,344.768  Millions
Regen Biopharma Inc   1.15 $ 0.237  Millions$ 0.206  Millions
Dynatronics Corporation  1.14 $ 30.784  Millions$ 27.017  Millions
Mettler toledo International Inc   1.14 $ 3,762.226  Millions$ 3,301.916  Millions
Nephros Inc   1.13 $ 12.683  Millions$ 11.191  Millions
Evolus Inc   1.13 $ 248.326  Millions$ 219.639  Millions
Vaso Corporation  1.12 $ 81.861  Millions$ 72.802  Millions
Puma Biotechnology Inc   1.12 $ 243.569  Millions$ 217.600  Millions
Sunshine Biopharma Inc   1.11 $ 32.959  Millions$ 29.651  Millions
Exagen Inc   1.11 $ 55.751  Millions$ 50.166  Millions
Medpace Holdings Inc   1.11 $ 2,070.866  Millions$ 1,864.182  Millions
Nuwellis Inc   1.11 $ 8.119  Millions$ 7.337  Millions
Amedisys Inc  1.10 $ 2,321.060  Millions$ 2,101.631  Millions
The Pennant Group Inc   1.10 $ 652.302  Millions$ 591.790  Millions
Universal Health Services Inc   1.09 $ 15,417.759  Millions$ 14,109.752  Millions
Pro dex Inc   1.09 $ 56.798  Millions$ 52.190  Millions
Precision Optics Corporation Inc   1.08 $ 18.980  Millions$ 17.530  Millions
Phibro Animal Health Corporation  1.07 $ 1,045.861  Millions$ 974.726  Millions
Equillium Inc   1.07 $ 45.914  Millions$ 42.861  Millions
Acadia Pharmaceuticals Inc   1.06 $ 929.236  Millions$ 873.757  Millions
Qhslab Inc   1.06 $ 1.821  Millions$ 1.719  Millions
Lifeloc Technologies Inc   1.06 $ 8.817  Millions$ 8.344  Millions
Inogen Inc   1.06 $ 331.520  Millions$ 314.221  Millions
Adma Biologics Inc   1.05 $ 381.124  Millions$ 361.769  Millions
Addus Homecare Corp  1.05 $ 1,132.106  Millions$ 1,076.970  Millions
Reshape Lifesciences Inc  1.05 $ 8.113  Millions$ 7.725  Millions
Inspire Medical Systems inc   1.04 $ 753.402  Millions$ 721.809  Millions
Eton Pharmaceuticals Inc   1.03 $ 33.607  Millions$ 32.550  Millions
Natera Inc   1.02 $ 1,531.955  Millions$ 1,504.460  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.